Core Insights - Medtronic has successfully performed the first U.S. commercial surgical case using its FDA-cleared Hugo™ robotic-assisted surgery (RAS) system at Cleveland Clinic, marking a significant milestone in expanding access to minimally invasive surgery [1] Company Developments - The first procedure was a robotic-assisted prostatectomy conducted by Dr. Jihad Kaouk, who emphasized the technology's ability to customize surgical approaches for individual patients [1] - The Hugo RAS system received FDA clearance for urologic surgical procedures in December 2025, and its introduction is part of Medtronic's broader surgical offerings [1] Industry Trends - Urology has seen a high adoption rate of robotic technology, with approximately 80% of urologic abdominal surgeries in the U.S. currently performed with robotic assistance, indicating a strong trend towards robotic-assisted procedures across various specialties [1] - The Hugo RAS system's modular design aims to address operating room scheduling challenges and infrastructure limitations, potentially increasing patient access to the benefits of minimally invasive care [1] Clinical Research - Cleveland Clinic participated in the Expand URO Investigational Device Exemption (IDE) clinical study, which demonstrated that the Hugo RAS system met primary safety and effectiveness endpoints in urologic surgeries [1] - The system is expected to expand its indications into gynecologic and general surgery procedures, including hernia repair, further broadening its application in the surgical field [1]

Core Insights - Medtronic has received FDA clearance for its Hugo robotic-assisted surgery (RAS) system for urologic procedures, enhancing options for hospitals and surgeons in the U.S. [1] - The Hugo RAS system aims to address challenges in robotic surgery capacity and access, providing a versatile platform for minimally invasive care [1] Group 1: Product Features - The Hugo RAS system features a modular design that allows robotic arms to be easily moved and shared across different care settings, maximizing utilization and providing flexibility for surgeons [1] - It integrates with the Touch Surgery ecosystem, offering pre-operative training tools, remote tele-proctoring, and AI-powered post-operative insights, facilitating continuous improvement in surgical practices [1] - Medtronic is the only company that meets surgeon needs across all surgical modalities, providing access to world-class robotic training and trusted technologies [1] Group 2: Market Impact - The Hugo RAS system is indicated for minimally invasive urologic procedures such as prostatectomy, nephrectomy, and cystectomy, which account for approximately 230,000 surgeries annually in the U.S. [1] - The system has been utilized in tens of thousands of surgeries across more than 30 countries, indicating its global acceptance and potential for expansion in the U.S. [1] - Medtronic plans to extend the Hugo RAS system's applications to additional surgical specialties, including general and gynecologic procedures, following its initial urology clearance [1]